Zi P Squared

Spencer Trask Applauds Better Care at Lower Cost for Biotech Products
NEW YORK, June 3 /PRNewswire/ -- Spencer Trask congratulates PROLOR Biotech, Inc. (NYSE/AMEX: PBTH) for ringing the NYSE opening bell at 9:29 am EDT today. PROLOR is a company co-founded and backed by Spencer Trask five years ago, and has recently been listed on the NYSE/AMEX and Tel Aviv stock exchanges.

New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference
Arrowhead Publishers and Conferences is pleased to announce the addition of three new speakers to their lineup at the Annual Personalized Medicine Partnerships Conference, set to take place on February 22nd through the 24th in Philadelphia, PA.

ASCP Joins ACLU Lawsuit Opposing Gene Patents
The American Society for Clinical Pathology (ASCP) has joined the American Civil Liberties Union (ACLU) in a lawsuit challenging the legality of patents on human genes -- specifically, patents covering the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. The lawsuit was filed against the U.S. Patent and Trademark Office, Myriad Genetics, and Directors of the University of Utah Research Foundation in U.S. District Court in the Southern District of New York on May 12.

CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents
The College of American Pathologists today joined a lawsuit against the U.S. Patent and Trademark Office and Myriad Genetics, challenging the legality of Myriad's patents for the genes known as BRCA1 and BRCA2, which are indicators for hereditary predisposition to breast and ovarian cancer.

World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage
World Alzheimer's Day 2008 Special Report: New innovative treatment approaches in Alzheimer's disease which involve mechanisms other than a direct attack on amyloid plaques have emerged as the leading candidates in the fight against Alzheimer's in 2008. These approaches were presented at ICAD 2008, the world's leading forum on dementia research. These new developments are discussed in the debut of AlzheimerVideoNews.com, a new website which takes a critical look at the most important news in Alzheimer's research.

Superstock Investor Releases November Issue; Leading Newsletter Reviews Entire Portfolio -- Jettisons Ten, Keeps Seven (BNI, WYE, MYGN, ERF, PWE, PGH
Superstock Investor (www.superstockinvestor.com) in its annual portfolio review has axed more than half of the current portfolio, reducing its tracking portfolio from 17 stocks to just seven, including: Burlington Northern Santa Fe (NYSE: BNI), Enerplus Resources Fund (NYSE: ERF), McAfee (NYSE: MFE), Myriad Genetics (Nasdaq: MYGN), Pengrowth Energy Trust (NYSE: PGH), Penn West Energy Trust (NYSE: PWE) and Wyeth (NYSE: WYE).

Home Site Map Advertise For Sale Subscribe to our Monthly Email Newsletter	Zi P Squared Spencer Trask Applauds Better Care at Lower Cost for Biotech Products NEW YORK, June 3 /PRNewswire/ -- Spencer Trask congratulates PROLOR Biotech, Inc. (NYSE/AMEX: PBTH) for ringing the NYSE opening bell at 9:29 am EDT today. PROLOR is a company co-founded and backed by Spencer Trask five years ago, and has recently been listed on the NYSE/AMEX and Tel Aviv stock exchanges. New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference Arrowhead Publishers and Conferences is pleased to announce the addition of three new speakers to their lineup at the Annual Personalized Medicine Partnerships Conference, set to take place on February 22nd through the 24th in Philadelphia, PA. ASCP Joins ACLU Lawsuit Opposing Gene Patents The American Society for Clinical Pathology (ASCP) has joined the American Civil Liberties Union (ACLU) in a lawsuit challenging the legality of patents on human genes -- specifically, patents covering the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. The lawsuit was filed against the U.S. Patent and Trademark Office, Myriad Genetics, and Directors of the University of Utah Research Foundation in U.S. District Court in the Southern District of New York on May 12. CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents The College of American Pathologists today joined a lawsuit against the U.S. Patent and Trademark Office and Myriad Genetics, challenging the legality of Myriad's patents for the genes known as BRCA1 and BRCA2, which are indicators for hereditary predisposition to breast and ovarian cancer. World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage World Alzheimer's Day 2008 Special Report: New innovative treatment approaches in Alzheimer's disease which involve mechanisms other than a direct attack on amyloid plaques have emerged as the leading candidates in the fight against Alzheimer's in 2008. These approaches were presented at ICAD 2008, the world's leading forum on dementia research. These new developments are discussed in the debut of AlzheimerVideoNews.com, a new website which takes a critical look at the most important news in Alzheimer's research. Superstock Investor Releases November Issue; Leading Newsletter Reviews Entire Portfolio -- Jettisons Ten, Keeps Seven (BNI, WYE, MYGN, ERF, PWE, PGH Superstock Investor (www.superstockinvestor.com) in its annual portfolio review has axed more than half of the current portfolio, reducing its tracking portfolio from 17 stocks to just seven, including: Burlington Northern Santa Fe (NYSE: BNI), Enerplus Resources Fund (NYSE: ERF), McAfee (NYSE: MFE), Myriad Genetics (Nasdaq: MYGN), Pengrowth Energy Trust (NYSE: PGH), Penn West Energy Trust (NYSE: PWE) and Wyeth (NYSE: WYE). Spencer Trask Applauds Better Care at Lower Cost for Biotech Products NEW YORK, June 3 /PRNewswire/ -- Spencer Trask congratulates PROLOR Biotech, Inc. (NYSE/AMEX: PBTH) for ringing the NYSE opening bell at 9:29 am EDT today. PROLOR is a company co-founded and backed by Spencer Trask five years ago, and has recently been listed on the NYSE/AMEX and Tel Aviv stock exchanges. Superstock Investor Releases November Issue; Leading Newsletter Reviews Entire Portfolio -- Jettisons Ten, Keeps Seven (BNI, WYE, MYGN, ERF, PWE, PGH Superstock Investor (www.superstockinvestor.com) in its annual portfolio review has axed more than half of the current portfolio, reducing its tracking portfolio from 17 stocks to just seven, including: Burlington Northern Santa Fe (NYSE: BNI), Enerplus Resources Fund (NYSE: ERF), McAfee (NYSE: MFE), Myriad Genetics (Nasdaq: MYGN), Pengrowth Energy Trust (NYSE: PGH), Penn West Energy Trust (NYSE: PWE) and Wyeth (NYSE: WYE). New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference Arrowhead Publishers and Conferences is pleased to announce the addition of three new speakers to their lineup at the Annual Personalized Medicine Partnerships Conference, set to take place on February 22nd through the 24th in Philadelphia, PA. CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents The College of American Pathologists today joined a lawsuit against the U.S. Patent and Trademark Office and Myriad Genetics, challenging the legality of Myriad's patents for the genes known as BRCA1 and BRCA2, which are indicators for hereditary predisposition to breast and ovarian cancer. World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage World Alzheimer's Day 2008 Special Report: New innovative treatment approaches in Alzheimer's disease which involve mechanisms other than a direct attack on amyloid plaques have emerged as the leading candidates in the fight against Alzheimer's in 2008. These approaches were presented at ICAD 2008, the world's leading forum on dementia research. These new developments are discussed in the debut of AlzheimerVideoNews.com, a new website which takes a critical look at the most important news in Alzheimer's research. ASCP Joins ACLU Lawsuit Opposing Gene Patents The American Society for Clinical Pathology (ASCP) has joined the American Civil Liberties Union (ACLU) in a lawsuit challenging the legality of patents on human genes -- specifically, patents covering the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. The lawsuit was filed against the U.S. Patent and Trademark Office, Myriad Genetics, and Directors of the University of Utah Research Foundation in U.S. District Court in the Southern District of New York on May 12.